A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Subjects
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 426 participants.
Also called NCT02345044
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 426 participants
- Sponsor
- Registry
-
NCT02345044
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT02345044. Randomized; quadruple masking; primary purpose treatment. Start 2015-01 (registry gives no type); primary completion 2015-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Subjects
- Condition
- Essential Hypertension
- Intervention (Drug)
- CS-3150
- Intervention (Drug)
- placebo
- Intervention (Drug)
- eplerenone
- Lead sponsor
- Daiichi Sankyo
Record details
- Record id
cardio:ct-nct02345044- Content hash
3800825ef4063252d37a568e29b9d46624edeed1a2179c847dc4d9de6ade84c7